Current status of thoracic endografting and its adjunctive pharmacology

Author： Khoynezhad Ali   Celis Rolando   Hashemzadeh Mehnoosh   Movahed Mohammad Reza   Jalali Ziba  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2871-2881

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: its current status as an anti-obesity drug

By Ballinger A.   Peikin S.R.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite

Leptin and the treatment of obesity: its current status

By Lee D.W.   Leinung M.C.   Rozhavskaya-Arena M.   Grasso P.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 129-139

Elsevier

Access to resources Recommend Favorite

Ergot Alkaloids: Current Status and Review of Clinical Pharmacology and Therapeutic Use Compared with Other Oxytocics in Obstetrics and Gynaecology

By N.J.A. de Groot A.  

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 523-535

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of If Current Inhibition

By  

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 21-24

Karger

Access to resources Recommend Favorite

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash   Henderson David C  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite